louisiana tirzepatide lawyer Liz Murrill becomes Louisiana's first woman attorney general • Illuminator The GLP-1 RA Legal Timeline:

On the other hand, $120 billion is pretty neatly just a little bit larger than a quarter of Novo Nordisk's market cap

Your unique medical history plays a major role in determining which medication is best

Key takeaways While losing 10 pounds in a month may be possible for some people, it may not be healthy or sustainable for others

Its important to rule out other potential causes like anemia or thyroid issues, which is why ongoing medical supervision is key

Semaglutide (Ozempic and Wegovy) resulted in a 14.9% reduction in body weight in clinical trials, while tirzepatide (Mounjaro and Zepbound) led to a 20.9% body weight reduction

The Pharmaceutical Benefits Advisory Committee has not recommended the listing of semaglutide (under its WeGovy branding) on the PBS for the treatment of obesity